Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 2/20 | 0.34 |
| ▸ | TYMS | P04818 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20393960 | 0.96 | MEN1 (0.36) | CA1CA2MGLLMEN1KMT2A | |
| SCHEMBL29557713 | 0.84 | MAPT (0.42) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL15676320 | 0.84 | MAPT (0.42) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL18819396 | 0.83 | MEN1 (0.34) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL21394016 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL21394113 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL21394241 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL21394019 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL20127193 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL21394116 | 0.82 | MAPT (0.39) | MEN1KMT2AKDM4ELMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12075695-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2024-08-27 | — | — | US | disclosed |
| US-11737357-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. | 2023-08-22 | — | — | US | disclosed |
| US-20230255104-A1 | Compound And Organic Light-Emitting Device Comprising Same | LG CHEM, LTD. (KR) | 2023-08-10 | — | — | US | disclosed |
| EP-3351537-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2023-01-18 | — | — | EP | disclosed |
| CN-108349914-B9 | Organic light emitting device | 株式会社LG化学 | 2021-09-03 | — | — | CN | disclosed |
| EP-3351536-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2021-07-21 | — | — | EP | disclosed |
| CN-108349913-B | Compound and organic light emitting device including the same | 株式会社LG化学 | 2021-06-29 | — | — | CN | disclosed |
| CN-108349914-B | Organic light emitting device | 株式会社LG化学 | 2021-06-29 | — | — | CN | disclosed |
| US-10367149-B2 | Organic light-emitting device | LG CHEM, LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-02-21 | — | — | US | disclosed |
| US-20180315930-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2018-11-01 | — | — | US | disclosed |
| EP-3351536-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
| EP-3351537-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2018-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737357-B2 | Compound and organic light-emitting device comprising same | CRY1, CYP1B1, CYP1A1 | CA1 1526/4885CA2 2733/4885MGLL 1318/4885 |
| US-20230255104-A1 | Compound And Organic Light-Emitting Device Comprising Same | ARL1, AR, ALG3 | CA1 3259/4885CA2 3902/4885MGLL 2384/4885 |
| US-10367149-B2 | Organic light-emitting device | CRY1, PPOX, CRY2 | CA1 3388/4885CA2 3650/4885MGLL 183/4885 |
| US-12075695-B2 | Compound and organic light-emitting device comprising same | ARL1, AR, ALG3 | CA1 3259/4885CA2 3902/4885MGLL 2384/4885 |
| US-20180315930-A1 | ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, CRY2 | CA1 3388/4885CA2 3650/4885MGLL 183/4885 |
| US-20190055222-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, CYP1A1 | CA1 1526/4885CA2 2733/4885MGLL 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.